Allworth Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Allworth Financial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-89	Closed	-$4.18K	–	5039
2025 Q2	$4.18K	Buy	89 +78	+709%	+$3.47K	﹤0.01%	3359
2025 Q1	$495	Buy	+11	New	+$506	﹤0.01%	3674
2024 Q3	–	Sell	-12	Closed	-$453	–	3829
2024 Q2	$453	Hold	12	–	–	﹤0.01%	3396
2024 Q1	$591	Buy	+12	New	+$555	﹤0.01%	3241
2022 Q4	–	Sell	-22	Closed	-$1K	–	3187
2022 Q3	$1K	Buy	22 +17	+340%	+$487	﹤0.01%	2509
2022 Q2	$0	Buy	+5	New	+$183	﹤0.01%	2797

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Allworth Financial's SWTX Position: Q3 2025 in Review

Allworth Financial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 89 shares — an estimated $4.18K sold.

Allworth Financial first reported a position in SWTX in Q2 2022 and held it in 6 quarters. The position peaked at $4.18K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Allworth Financial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Allworth Financial sold 89 SpringWorks Therapeutics shares in Q3 2025, an estimated $4.18K.
Allworth Financial first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 6 quarters.
Allworth Financial's SpringWorks Therapeutics position peaked at $4.18K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.